Literature DB >> 30470158

Computational study of conformational changes in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding.

Clauber Henrique Souza Costa1, Amanda Ruslana Santana Oliveira1, Alberto M Dos Santos2, Kauê Santana da Costa3, Anderson Henrique Lima E Lima1, Cláudio N Alves1, Jerônimo Lameira2.   

Abstract

The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is mainly involved in the regulation of cholesterol biosynthesis. HMGR catalyses the reduction of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) to mevalonate at the expense of two NADPH molecules in a two-step reversible reaction. In the present study, we constructed a model of human HMGR (hHMGR) to explore the conformational changes of HMGR in complex with HMG-CoA and NADPH. In addition, we analysed the complete sequence of the Flap domain using molecular dynamics (MD) simulations and principal component analysis (PCA). The simulations revealed that the Flap domain plays an important role in catalytic site activation and substrate binding. The apo form of hHMGR remained in an open state, while a substrate-induced closure of the Flap domain was observed for holo hHMGR. Our study also demonstrated that the phosphorylation of Ser872 induces significant conformational changes in the Flap domain that lead to a complete closure of the active site, suggesting three principal conformations for the first stage of hHMGR catalysis. Our results were consistent with previous proposed models for the catalytic mechanism of hHMGR. Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Cholesterol; HMGR; PCA; conformational changes; molecular dynamics

Year:  2019        PMID: 30470158     DOI: 10.1080/07391102.2018.1549508

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  6 in total

1.  Enhancement of Squalene Production by Constitutive Expression of the 3-Hydroxy-3-Methylglutaryl-CoA Reductase in Aurantiochytrium sp. 18W-13a.

Authors:  Tianjing Yang; Darryl Joy Juntila; Naomichi Fujihara; Takashi Inada; Kohei Yoneda; Iwane Suzuki
Journal:  Mar Biotechnol (NY)       Date:  2022-07-16       Impact factor: 3.727

2.  Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.

Authors:  Clauber Henrique Souza da Costa; Camila Auad Beltrão de Freitas; Cláudio Nahum Alves; Jerônimo Lameira
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

3.  Investigation of the target-site resistance of EPSP synthase mutants P106T and T102I/P106S against glyphosate.

Authors:  Emily C M Fonseca; Kauê S da Costa; Jerônimo Lameira; Cláudio Nahum Alves; Anderson H Lima
Journal:  RSC Adv       Date:  2020-12-16       Impact factor: 4.036

4.  Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach.

Authors:  Richelly Cardoso; Renan Valente; Clauber Henrique Souza da Costa; João Lidio da S Gonçalves Vianez; Kauê Santana da Costa; Fábio Alberto de Molfetta; Cláudio Nahum Alves
Journal:  Molecules       Date:  2021-05-12       Impact factor: 4.411

5.  Using Accelerated Molecular Dynamics Simulation to elucidate the effects of the T198F mutation on the molecular flexibility of the West Nile virus envelope protein.

Authors:  Renan Patrick da Penha Valente; Rafael Conceição de Souza; Gabriela de Medeiros Muniz; João Elias Vidueira Ferreira; Ricardo Morais de Miranda; Anderson Henrique Lima E Lima; João Lídio da Silva Gonçalves Vianez Junior
Journal:  Sci Rep       Date:  2020-06-15       Impact factor: 4.379

6.  Exploring the Potentiality of Natural Products from Essential Oils as Inhibitors of Odorant-Binding Proteins: A Structure- and Ligand-Based Virtual Screening Approach To Find Novel Mosquito Repellents.

Authors:  Kauȇ Santana da Costa; João Marcos Galúcio; Clauber Henrique Souza da Costa; Amanda Ruslana Santana; Vitor Dos Santos Carvalho; Lidiane Diniz do Nascimento; Anderson Henrique Lima E Lima; Jorddy Neves Cruz; Claudio Nahum Alves; Jerônimo Lameira
Journal:  ACS Omega       Date:  2019-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.